
Ane Gerda Z Eriksson MD PhD
@agz_eriksson
Followers
4K
Following
25K
Media
263
Statuses
5K
Head of GynOnc, Radiumhospitalet @Oslounivsykehus | Ass. Prof. @UniOslo_MED | @MSKCancerCenter & @harvardmed GCSRT alumni | @ESGO_society Council | @OncoAlert
Oslo, Norway
Joined January 2015
🏥I’m happy to share that I’m starting a new position as Head of Gynecologic Oncology at The Norwegian Radium Hospital, @Oslounivsykehus . 🤩Grateful for the opportunity to lead this wonderful group 👩🏼⚕️👩🏻⚕️👨🏻⚕️. @YunWang41041765 @ESGO_society @UniOslo_MED @OncoAlert
27
4
104
RT @ChrisDagherMD: Opportunistic salpingectomy remains an area or active research where more work is needed. Proud to have contributed to t….
0
5
0
RT @IJGConline: Rectosigmoid colon resection vs rectosigmoid wall stripping for superficial rectal wall tumors at cytoreductions for advanc….
0
17
0
RT @JAMANetworkOpen: RCT: #Pulmonary rehabilitation using minimal equipment was noninferior to rehabilitation with specialist gym equipment….
0
14
0
RT @OncoAlert: Join us for the 44th Annual Congress of the European Society of Surgical Oncology (ESSO 44) @ESSOnews Gothenburg, Sweden🇸🇪….
0
13
0
RT @ESGO_society: New speaker alert! 💥.We’re pleased to update you that Christina Fotopoulou 🇬🇧 will join our webinar on Sept 15 to share h….
0
3
0
RT @ESGO_society: Recently published in The International Journal of Gynecologic Cancer ‼️ 🗞️ ESGO/INCIP Guidelines for the management of p….
0
8
0
RT @ESGO_society: Coming up in September: The ESGO Prevention Commitee is co-hosting 🤝 a conference in Serbia with the Serbian Society for….
0
1
0
RT @ESGO_society: Precision medicine is one of the most important recent medical developments. Join ESGO experts at the Molecular Pathology….
0
2
0
RT @ENYGO_official: Dear colleagues, listen to ENYGO national representative from Ukraine, Dr. Teimuraz Gogisvanidze, and join us for the m….
0
1
0
Congratulations @ErinGeorgeMD & team 🎉🎊🙌🏼👏🏼.
Excited to share a glimpse into the future of cancer modeling at @MoffittNews. This 3D patient-derived microtumor, developed as a “Patient Avatar” for ovarian cancer research, was cultured for 14 days under continuous perfusion, preserving its microenvironment and cellular
0
0
1
RT @ENYGO_official: Join us in Tbilisi, Georgia for the fantastic Masterclass 2025. Check the website for more information. Link:.https:/….
0
2
0
RT @EngageEsgo: We can’t wait to see what you all have have planned for our gynae cancer awareness day on September 20—World Gynecologic On….
0
5
0
RT @ESGO_society: For our @enygo_official members—don’t miss the Masterclass this October!. Join Local Chair Archil Sharashenidze 🇬🇪, ESGO….
0
2
0
RT @OncoAlert: Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refract….
0
9
0
RT @ESGO_society: Just published in The Lancet! ‼️🗞️ ESGO-ESTRO-ESP Guidelines for the Management of Patients with Endometrial Carcinoma:….
0
40
0
Great opportunity for anyone interested in clinical research in #GynOncology 👇. @ENYGO_official @OncoAlert @IJGCfellows.
.We have advertised for a Clinical Research Fellow to work in our Clinical Academic Team @wpp_wiph .@NHSBartsHealth .We run a number of studies in precision prevention of Women’s cancers .Come and join our team .Please RT.
0
2
5
RT @ESGO_society: Tick one thing off your summer to-do list—submit your abstract for #ESGO2026 now!. Guidelines & submission info 👉 https:/….
0
4
0
RT @DrYukselUrun: Obesity isn't just weight, it's a disease linked to fat distribution and major health risks. 🧠 Stroke.💓 Heart disease.🎯 D….
0
18
0